AZBio In The Loop for the Week of November 13, 2017

Join us for Beer & Bio with the AZBio Board at GlobalMed on Nov. 16th.  It’s FREE!

 REGISTER Today!  

AZBio Member News


Iron Horse Diagnostics receives MDA Venture Philanthropy Grant to Support Development of ALS Biomarkers

Project aims to develop a prognostic test to improve prediction of ALS disease progression 

AMAG Announces Autologous Cord Blood Cells Improve Motor Function in Some Children with Cerebral Palsy

More than one-third of study participants in Phase 2 Study were Cord Blood Registry® (CBR®) clients.

EndoVantage Secures 510(k) Clearance from FDA for SurgicalPreview™

Preoperative Planning Tool Has the Potential for Changing the Management of Cerebral Aneurysm Treatment

FDA approves Roche’s VENTANA ALK (D5F3) CDx Assay for use on the VENTANA BenchMark ULTRA system

Roche (SIX: RO, ROG; OTCQX:RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved the VENTANA ALK (D5F3) CDx Assay1 for use on the VENTANA BenchMark ULTRA automated slide stainer. The assay is a companion diagnostic to aid in the identification of ALK-positive lung cancer patients who are eligible for treatment with Pfizer’s FDA-approved therapy XALKORI®(crizotinib).

EpiFinder takes its story to KickStarter

EpiFinder offers a proven tool that empowers people to take ownership of their health, connect with their doctor, advance epilepsy and neurology research and is telling their story on KickStarter.

Preventing Heart Disease Among Hispanic Diabetes Patients in Arizona, Focus of UA Research

Reducing cardiovascular disease and complications among Hispanic diabetes patients in Arizona is the focus of a new research project for Tomas Nuño, PhD, assistant professor of public health practice and translational research at the UA Mel and Enid Zuckerman College of Public Health – Phoenix and the Department of Emergency Medicine at the UA College of Medicine – Tucson

UA Scientists Awarded Space Research Grant

NASA grant will allow the Center for Applied NanoBioscience and Medicine to study the health effects of long space missions

Banner Alzheimer’s Institute, Novartis, and Amgen Expand Collaboration in Pioneering Alzheimer’s Prevention Program

Second study to probe whether an investigational drug can prevent or delay the emergence of symptoms in high-risk older adults

Nine Life Science Companies Make The Top 5 in the Fall 2017 Arizona Innovation Challenge Finals

The Arizona Commerce Authority has announced the 25 semifinalists in the Fall 2017 round of the Arizona Innovation Challenge.  The semifinalists include: Breezing Co. (Tempe), GT Medical Technologies (Gilbert), Life365 Inc. (Tempe), Merchant’s Garden AgroTech Inc. (Tucson), MicronView LLC (Tucson), NanoPin Technologies Inc. (Phoenix), Resonea (Scottsdale), SkinSafe Inc. (Scottsdale), and VB Cosmetics Inc. (Chandler).

Munk appointed deputy director of ASU’s Biodesign Institute

Stephen Munk has joined the Biodesign Institute at Arizona State University as deputy director of science and technology. In this role, Munk will focus on the strategic, business and technical operations of Arizona’s single largest bioscience research infrastructure investment.

UA Cancer Center Research Team Explores Anti-Breast Cancer Properties of Soy

A University of Arizona Cancer Center and College of Agriculture and Life Sciences research team is engaged in a series of studies to investigate how genistein, a component of soy foods, might suppress the development of breast cancer.

Startup Regulonix Licenses University of Arizona Non-opioid Pain Drug Candidates

Tucson, Ariz. – Researchers in the University of Arizona College of Medicine – Tucson have invented a new class of non-opioid compounds to treat pain. Animal testing has shown that the drug candidates are more effective than morphine,  non-addictive, and  non-toxic at high doses. The UA has licensed the compounds to startup Regulonix. 

Startup Licenses University of Arizona Technology That Shortens Cancer Cell Life

The University of Arizona has licensed a drug that aims to shorten the lives of cancer cells to startup Reglagene. The technology, invented at the UA College of Pharmacy and the UA BIO5 Institute by Laurence Hurley, PhD, and Vijay Gokhale, PhD, has been shown to be effective in shortening the lives of target cells, essentially inducing cancer cells to grow old and die.

Young Entrepreneurs Receive FDA Clearance for Medical Device Poised to Disrupt Newborn Care Market

Through its empathy-driven innovation model, NeoLight develops technologies that treat infants with life threatening medical conditions.


Opportunity Alerts

Understand Your Genome Symposium 

(Sign Up by Nov. 17th to get your genome sequenced!)

AZBio Members – Lock-in Your Savings for BIO 2018 by January 12th.  

Save Big When You Are Ready to Register for BIO 2018 in Boston.As a valued member of a state biotech association, we’re offering you the opportunity to lock in a significant discount on two premier BIO 2018 registration packages: Convention Access and Convention Access & Partnering.  Registration is not required at this point. By signing up, you are locking in the discount. Simply complete the form, and you will be sent your discount code prior to registration opening in January. It’s that easy!

Post your open career opportunities today at

Who’s Hiring?  

Check out career opportunities with Cancer Prevention Pharmaceuticals, Critical Path Institute, Regenesis Biomedical, and Systems Imagination (Internship). 


Do YOU have news to share with our community? 

Send your news and events to

Events  – Committees – Savings

Get Connected – Sign up today! 

  • Dec 14, 2017 – Phoenix
State Biotech Kick Off Reception – JPM Week

  • Jan 7, 2018 – San Francisco

  • Jan 9, 2018 – San Francisco

Biotech Showcase 2018  (AZBio Members Save)

  • Jan 8-10, 2018 – San Francisco

Digital Medicine and Medtech Showcase  (AZBio Members Save)

  • Jan 8-10, 2018 – San Francisco
Understand Your Genome Symposium  (Sign Up by Nov. 17th to get your genome sequenced!)

  • Feb 22, 2018 – Scottsdale

White Hat Investors Conference during AZBW 2018

  • Oct 3-4, 2018 – Phoenix

Save the date: AZBio Government Affairs Call: Thursday January 11th at 3 PM 
All AZBio Members are welcome to join the AZBio Government Affairs Committee.  Click here to be added to the committee    Click here to download our 2018 Plans

SAVINGS: AZBio Purchasing Power


AZBio Members saved over $3 Million via AZBio Purchasing Power in 2016. 

 Click here to learn more how YOU can save on these product and services. 


Join  AZBio

AZBio is committed to making
Arizona a Top Tier Bioscience State. 
AZBio Members are making it happen!View AZBio Member Directory
To learn more about AZBio click here     

 Thank you to our AZBio Supporters

Legacy Level:  Arizona Commerce Authority * BIO *  Dorn Policy Group  * Flinn Foundation 
Chairman’s Circle:  Bard Peripheral Vascular  *  BusinessWire 
City of Phoenix * City of Tempe *  
Johnson & Johnson * Roche 
Leadership Level: Alliant Insurance * Amanda Vega Consulting * Amgen * Arizona Science Center * City of Scottsdale *  Cord Blood Registry (CBR) * Dignity Health * Genentech  * Janssen Biotech * KCA * Medtronic Tempe Campus * New Angle Media *   Northern Arizona University  *  Pfizer *  PhRMA * Pinnacle Transplant Technologies * Roche Diagnostics *  TGen * The Biodesign Institute at ASU * UA BIO5 * Ulthera * University of Arizona * Ventana Medical Systems * VWR   
Sustaining Partners:  AdvaMed  * Affordable Image * Alliance Bank of Arizona *  Allergan  *  APS * Bank of America * Bristol-Myers Squibb *  EY * International Research Center * Merrill Lynch * Midwestern University * NFP * * PADT Medical * Snell & Wilmer * U.S. Trust  

AZBio Supporters make what we do possible.

 Download the 2018 AZBio Prospectus to learn more.

Copyright © 2017 AZBio. All rights reserved.
Arizona BioIndustry Association, Inc.



Posted in AZBio News, In the Loop.